Literature DB >> 26691174

Late Recurrence of Low-Risk Stage II Colorectal Cancer Shortly After Etanercept.

Tony Ibrahim1, Khalil Saleh2, Viviane Track-Smayra3, Nelly Ziade4, Dalia Sarraf5, Charbel Yazbeck6, Nadine Khalife2, Fadi Nasr2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26691174     DOI： 10.1007/s12029-015-9788-y

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  9 in total

1.  RETRACTED: Obesity-induced increase in tumor necrosis factor-α leads to development of colon cancer in mice.

Authors:  Marcelo B S Flores; Guilherme Z Rocha; Danilo M Damas-Souza; Felipe Osório-Costa; Marília M Dias; Eduardo R Ropelle; Juliana A Camargo; Rita B de Carvalho; Hernandes F Carvalho; Mario J A Saad; José B C Carvalheira
Journal:  Gastroenterology       Date:  2012-06-04       Impact factor: 22.682

2.  Risk of Lymphoma, Colorectal and Skin Cancer in Patients with IBD Treated with Immunomodulators and Biologics: A Quebec Claims Database Study.

Authors:  Uri Kopylov; Maria Vutcovici; Abbas Kezouh; Ernest Seidman; Alain Bitton; Waqqas Afif
Journal:  Inflamm Bowel Dis       Date:  2015-08       Impact factor: 5.325

3.  Tumor necrosis factor in advanced colorectal cancer: a phase II study. A trial of the phase I/II study group of the Association for Medical Oncology of the German Cancer Society.

Authors:  M E Heim; R Siegmund; H J Illiger; M Klee; K Rieche; W E Berdel; L Edler
Journal:  Onkologie       Date:  1990-12

4.  Human Kupffer cells are cytotoxic against human colon adenocarcinoma.

Authors:  M S Roh; L Wang; C Oyedeji; M E LeRoux; S A Curley; R E Pollock; J Klostergaard
Journal:  Surgery       Date:  1990-08       Impact factor: 3.982

5.  Phase II study of recombinant human tumor necrosis factor in colorectal carcinoma.

Authors:  M Schaadt; M Pfreundschuh; G Lorscheidt; K M Peters; T Steinmetz; V Diehl
Journal:  J Biol Response Mod       Date:  1990-04

6.  Inflammatory cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers.

Authors:  W M U van Grevenstein; L J Hofland; M E E van Rossen; P M van Koetsveld; J Jeekel; C H J van Eijck
Journal:  Dig Dis Sci       Date:  2007-03-30       Impact factor: 3.199

7.  The inhibition of TNF-alpha anti-tumoral properties by blocking antibodies promotes tumor growth in a rat model.

Authors:  Nicolas Larmonier; Dominique Cathelin; Claire Larmonier; Alexandra Nicolas; Delphine Merino; Nona Janikashvili; Sylvain Audia; Andrew Bateman; Jill Thompson; Tim Kottke; Thomas Hartung; Emmanuel Katsanis; Richard Vile; Bernard Bonnotte
Journal:  Exp Cell Res       Date:  2007-03-30       Impact factor: 3.905

8.  Colorectal cancer severity and survival in correlation with tumour necrosis factor-alpha.

Authors:  Noyko Stanilov; Lyuba Miteva; Zlatka Dobreva; Spaska Stanilova
Journal:  Biotechnol Biotechnol Equip       Date:  2014-10-29       Impact factor: 1.632

9.  Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

Authors:  Louise K Mercer; Mark Lunt; Audrey L S Low; William G Dixon; Kath D Watson; Deborah P M Symmons; Kimme L Hyrich
Journal:  Ann Rheum Dis       Date:  2014-03-31       Impact factor: 19.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.